Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment - Trial NCT06394544
Access comprehensive clinical trial information for NCT06394544 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidade Federal Fluminense and is currently Not yet recruiting. The study focuses on Chronic Kidney Diseases,Chronic Kidney Disease stage3,Chronic Kidney Disease Stage 3A,Chronic Kidney Disease Stage 3B,Chronic Kidney Disease stage4,Inflammation,Inflammatory Response,Oxidative Stress,Intestinal Microbiota. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Universidade Federal Fluminense
Timeline & Enrollment
N/A
Aug 01, 2024
Mar 01, 2027
Primary Outcome
Change in antioxidants and anti-inflammatory biomarkers
Summary
The aim of this study is to evaluate the effects of Brazil nut supplementation on
 inflammation, oxidative stress and intestinal microbiota in patients with chronic kidney
 disease undergoing conservative treatment.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06394544
Non-Device Trial